Guzip Biomarkers Corporation is a 2018 spin-out company from Taipei Medical University. Guzip is a research-driven company looking forward to providing novel DNA methylation epigenetic biomarkers for applications in the clinic. With a view to providing health management units as the basis for personalized medicine and contributing to improving women’s health, our first project’s goal is to develop...